2012 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2007 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2017 | 0 | 5.971.174 | 144.375 | 1 | ||
2012 | 0 | 5.962.458 | 20.399 | 1 | ||
2011 | 0 | 3.282.912 | 298.447 | 1 |
Total number of partners: 29
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 29
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2017-01-01 | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery | TreatER | participant | 5.971.174 | 11 |
2012-01-01 | Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in ParkinsonĀ“s disease | NRT | participant | 5.962.458 | 10 |
2011-11-01 | Personal Health Device for the Remote and Autonomous Management of Parkinson's Disease | REMPARK | participant | 3.282.912 | 11 |